Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00469

Submission Number:
00469
Commenter:
Wright
State:
Florida
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
CVS has an anticompetitive advantage. CVS owning Caremark should have never been allowed. It's a clear violation and drives health Care costs upward. The largest retail pharmacy owning the largest PBM is a clear conflict and they can benefit from a self referral relationship.